ARCHIVES

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 19 No. 04 | January 22, 1993

Download PDF Visit The Full Archive

Related Articles

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

Obit: George Santos, Hopkins Cancer Treatment Pioneer.

January 26, 2001

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997